Skip to main content

Co-pay Assistance Program

Contact us: (877) 557-2672 | [email protected]

Medical debt?

Learn about the Medical Debt Case Management Program

Cancer care shouldn’t be a financial burden. We’re helping patients find options to address their medical debt.

The Co-pay Assistance Program [[toc="Overview"]]

Provideing assistance toward the cost of Private, Medicare, Medicaid, and TRICARE insurance premiums, and treatment-related co-pays and co-insurance for prescription drugs, labs, scans, tests, etc. 

Award levels vary by disease fund. 

Track your application or claim

Access the current status of applications, award coverage, award balances, claim submissions, and payment details.

Search now

Questions? Download the Tracking Tool Quick Reference Guide (PDF).

Available funding

Funding for the Co-pay program is provided by pharmaceutical and biotech companies and is not supported by other sources of revenue including our fundraising campaigns such as Team In Training, Light The Night, Student Series, Leukemia Cup Regatta, Man & Woman of the Year, or Student of the Year. These campaigns support Blood Cancer United patient education, support services, advocacy, and research.

A fund that is “closed” is at maximum capacity, serving those enrolled, and is not enrolling additional patients (new or renewal patients). We do not keep a waitlist and encourage all to continue to check the website for updates.

Apply now

Please note: Changes to funds are reflected on this webpage as quickly as possible. For up-to-the-minute fund status, please call (877) 557-2672. If you started an application prior to a fund becoming fully subscribed, please continue with the application.

Closed
Acute Lymphoblastic Leukemia (ALL)
Up to $3,500
Covered diagnoses
  • Acute lymphoblastic leukemia (ALL)
Closed
Acute Myeloid Leukemia (AML)
Up to $4,000
Covered diagnoses
  • Acute myeloid leukemia (AML)
  • Acute promyelocytic leukemia (APL)
  • BPDCN
  • Erdheim Chester Disease
  • Mast cell leukemia
  • Mastocytosis
Open
Chronic Lymphocytic Leukemia (CLL)*
Up to $4,500
Covered diagnoses
  • Chronic lymphocytic leukemia (CLL or SLL)
  • B cell prolymphocytic leukemia (B PLL)
  • Hairy cell leukemia (HCL)
  • Large granular lymphocytic leukemia (LGL)
  • Richter's transformation of CLL
Soliciting
Clinical Trials
Up to $3,500
Covered diagnoses
  • Patients with blood cancer enrolled in a blood cancer clinical trial
Closed
Lymphoma
Up to $4,000
Covered diagnoses
  • Hodgkin lymphoma (HL)
  • All Non Hodgkin lymphomas (NHL)
  • Lymphomatoid papulosis
  • Post transplant lymphoproliferative disorder or PTLD
Closed
Mantle Cell Lymphoma (MCL)
Up to $4,000
Covered diagnoses
  • Mantle cell lymphoma (MCL)
Open
Myelodysplastic Syndromes (MDS)
Up to $3,500
Covered diagnoses
  • Myelodysplastic syndromes (MDS)
  • Chronic myelomonocytic leukemia (CMML)
  • Juvenile myelomonocytic leukemia (JMML), diagnosis formerly known as chronic myelomonocytic leukemia of infancy [CMML]
  • MDS/MDP overlap syndrome
Closed
Myeloma
Up to $5,000
Covered diagnoses
  • Myeloma or multiple myeloma (MM)
  • Plasma cell leukemia or plasma cell myeloma
  • POEMS syndrome
  • MGUS
Closed
Myeloproliferative Neoplasms (MPN)
Up to $4,000
Covered diagnoses
  • Myelofibrosis (MF)
  • Essential thrombocythemia (ET)
  • Polycythemia Vera (PV)
  • Chronic Neutrophilic Leukemia (CNL)
  • Chronic Eosinophilic Leukemia (CEL)

Philadelphia chromosome negative myeloproliferative neoplasms only.

Closed
Waldenstrom Macroglobulinemia (WM)
Up to $4,000
Covered diagnoses
  • Waldenstrom macroglobulinemia (WM)

*The Chronic Myeloid Leukemia (CML) Co-pay fund is fully subscribed but not permanently closed.

As a non-profit organization, we rely on the generosity of our sponsors. Program continuation is dependent on the availability of funds and the program could be modified or discontinued at any time if funding is limited or no longer available. Please visit our website in the future to become aware of new funding.

*Based upon historical and recent trends, we anticipate that the CLL Co-pay fund will be open through the winter of 2025.

The Inflation Reduction Act highlights changes in Medicare for 2024 and 2025:

  • For Medicare plan year 2024 patients will see a new limit on their cost-sharing for their Part D drugs
    • If a patient is taking exclusively brand drugs: they will reach the out-of-pocket cap at around $3,300.
    • If a patient is taking exclusively generic drugs: they will reach the out-of-pocket cap at $8,000.
  • Starting in 2025 there will be a new $2,000 annual cap on Medicare patients’ out-of-pocket prescription drug costs

Additional resource links:

https://www.cms.gov/inflation-reduction-act-and-medicare

https://www.cms.gov/files/document/10522-inflation-reduction-act-timeline.pdf

We can help pay for:

  • Medical insurance premiums
  • Treatment-related co-pays, deductibles, and co-insurance (for expenses covered by the program)
  • Co-pays for prescription medication related to prescribed treatment
  • Co-pays for non-diagnostic labs, scans, and tests.

Blood Cancer United can pay your provider directly or reimburse you for payments already made. You have complete freedom to choose doctors, providers, suppliers, insurance companies and treatment-related medications. You can make changes to these at any time without affecting your continued eligibility.

*Updated* See a list of covered and non-covered expenses (PDF).

To be eligible for Co-pay assistance, you must

  • Be a United States citizen or permanent resident and reside in the U.S. or a U.S. territory.
    • Members of the U.S. military, diplomats, etc. who may be serving overseas, must have a U.S. address and use it on the application.
  • Have a household income that is at or below 600 percent of the U.S. federal poverty guidelines (PDF) as adjusted by the Cost of Living Index (COLI). You will be asked for your zip code to determine your COLI.
  • Have medical insurance
  • Have a blood cancer diagnosis confirmed by a doctor
    • The patient must be in active treatment, scheduled to begin treatment, or is being monitored by their doctor.
    • For members of the U.S. military, diplomats, etc. who may be serving overseas, the healthcare provider attesting to the diagnosis must have a National Provider Identification (NPI) number and use it on the application.

You may call (877) 557-2672 to speak with an Intake Specialist who can walk you through the application process. If you prefer to apply on your own, please refer to the information below.

STEP 1: Gather the following information. 

  • The patient's demographic information (including their Social Security number and date of birth) and their contact information.
    • If the patient is a minor, you will need a guardian Social Security number as well.
  • The name of your diagnosis.
  • Estimated household financial income.
  • Insurance card, as well as Medicare/Medicaid.
  • The name of your pharmacy and its phone/fax numbers.
  • The name of treating physician and their phone/fax numbers.

This information will not be shared and is for verification purposes only.

*Healthcare Professionals (HCP) applying on behalf of a patient will be asked for their NPI and tax ID.

In the event that you are unable to get your doctor to sign off on the Diagnosis Verification Form for your application, we will accept a portion of your electronic medical record (EMR) or other documentation that shows the diagnosis/ICD-10 code.

STEP 2: Register and/or apply

Blood Cancer United offers patients, caregivers, pharmacies, and healthcare providers two easy ways to register/apply:  

By Phone: (877) 557-2672
Monday to Friday, 8:30 a.m. to 5:00 p.m.

OR

Co-pay online: Online portal 
24/7, Available in English only

If you do not have an Blood Cancer United Financial Assistance Copay Portal Account:

If this is your first time visiting the Blood Cancer United Financial Assistance Co-pay Portal, you will need to register before you can start the online application. To create a portal account :

If you already have an Blood Cancer United Financial Assistance Co-pay Portal Account:

If you are returning to the Blood Cancer United Financial Assistance Co-pay Portal, please log in, select Co-Pay Assistance Program, and fill out required fields.

Need Help?

For portal technical support, please call us at (877) 557-2672 or e-mail [email protected].

Approved patients must submit a claim for a covered expense every 90 days to keep their accounts active.

How to Submit a Claim

See our claim videos to view our claim videos that provide step-by-step instructions on how to submit a claim

You may also contact the Co-pay Assistance Program at (877) 557-2672 for instructions on how to submit a claim.

As a charity, Blood Cancer United is exempt from federal income tax and individuals who receive assistance from a charity to meet their personal needs do not generally have to pay federal income tax on the value of the assistance they receive. With this being said it should not affect their ability to receive financial assistance from the government or affect their income taxes. 

Blood Cancer United
Co-pay Assistance Program 
P.O. Box 12268
Newport News, VA 23612

Email: [email protected]
Toll Free Phone: (877) 557-2672
Fax: (877) 267-2932

Understand Insurance Basics


We are Blood Cancer United.

Everyone affected by blood cancer has a story. Share yours. 

How has this program helped you?  Let us know how the financial assistance provided by Blood Cancer United has helped you. Patient stories like yours illustrate the impact and importance of this program in the lives of blood cancer patients.

Share your story 

See all stories.

Blood Cancer United resources

Find free, specialized guidance and information for every type of blood cancer, request financial support, find emotional support, and connect with other members of the blood cancer community.

We are Blood Cancer United.

Everyone affected by blood cancer—patients, survivors, caregivers, researchers, advocates, fundraisers, everyone—has a story. Share yours.
Headshot of Imani in her white nursing coat

Imani

myelodysplastic syndrome (MDS)

Fast Company Brands That Matter 2022 Logo

Chase

Leukemia Survivor

Jay, volunteer, and friend in candid photo

Jay

Volunteer

Manny smiling wide at 10ish years old in a white shirt

Emmanuel "Manny"

Acute myeloid leukemia (AML)

Snapshot of Blaine Davis in hospital room, a cancer survivor

Blaine

Leukemia Survivor

Katie, primary mediastinal large B-cell lymphoma (PMBCL) patient

Katie

primary mediastinal large B-cell lymphoma (PMBCL)

Merton

multiple myeloma (MM)

OLYMPUS DIGITAL CAMERA

Melissa

Caregiver

Holly

subcutaneous panniculitis-like T-cell lymphoma (SPTCL)

Lori

follicular lymphoma (FL)

Michael and Ashlee

hepatosplenic T-cell lymphoma (HSTCL)

Paul

multiple myeloma (MM) and myelodysplastic syndrome (MDS)

The Leukemia & Lymphoma Society (LLS) is now Blood Cancer United. Learn more.